StockWatch
·
Biotechnology: Biological Products (No Diagnostic Substances)
Corporate ActionJun 29, 2026, 05:21 PM

Z Squared Raises $15.3M in Equity, Completes SEPA Use

AI Summary

Z Squared Inc. announced it raised approximately $15.3 million in capital through equity sales under its standby equity purchase agreement (SEPA), completing its use of the arrangement. This all-equity financing adds growth capital without incurring new debt, strengthening the balance sheet to advance its AI infrastructure strategy. Additionally, the company confirmed its inclusion in the Russell 3000® and Russell 2000® Indexes, effective June 26, 2026, which is expected to increase visibility among institutional investors.

Key Highlights

  • Z Squared raised approximately $15.3 million in capital through equity sales under its standby equity purchase agreement (SEPA).
  • The financing was all-equity, incurring no new debt, and the company maintains virtually no corporate debt.
  • The company issued 1,302,806 shares of common stock to YA II PN, Ltd. at $11.8351 per share.
  • Net proceeds will support the company's acquisition and conversion strategy and for general corporate purposes.
  • Z Squared completed its use of the legacy equity financing arrangement (SEPA).
  • The company confirmed its official inclusion in the Russell 3000® Index and the Russell 2000® Index.
  • Index inclusion was effective after the market close on June 26, 2026.